4//SEC Filing
IDEXX LABORATORIES INC /DE 4
Accession 0000899243-16-013156
$IDXXCIK 0000874716operating
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 7:45 PM ET
Size
9.5 KB
Accession
0000899243-16-013156
Insider Transaction Report
Form 4
JOHNSON BARRY C
Director
Transactions
- Exercise/Conversion
Common Stock
2016-02-09$17.18/sh+9,054$155,593→ 12,614 total - Sale
Common Stock
2016-02-09$68.90/sh−9,054$623,788→ 3,560 total - Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2016-02-09−9,054→ 0 totalExercise: $17.18Exp: 2016-02-13→ Common Stock (9,054 underlying)
Footnotes (4)
- [F1]The number of securities reported reflects a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015 (the "Stock Split").
- [F2]The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $68.90 to $68.93 inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- [F3]Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,527 shares on February 14, 2010, without giving effect to the 2-for-1 "Stock Split". The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- [F4]Not applicable.
Documents
Issuer
IDEXX LABORATORIES INC /DE
CIK 0000874716
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000874716
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 7:45 PM ET
- Size
- 9.5 KB